Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFCD 1102
2011-006266-41Phase 2Active
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jan 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan, oxaliplatin, folinic acid, fluorouracil in cancer, sponsored by Fédération Francophone de Cancérologie Digestive. Started Jan 2012; status: active.
02
Drugs
irinotecanoxaliplatinfolinic acidfluorouracil
03
Conditions
cancer
Beyond the preview
Go deeper on 2011-006266-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006266-41.